1. ALLA AKTIER
  2. NYHETER
  3. BBS-BIOACTIVE BONE SUBSTITUTES

BBS-Bioactive Bone Substitutes

Nyheter BBS-Bioactive Bone Substitutes Nyheter alla bolag

BBS-Bioactive Bone Substitutes Plc - Insider information: BBS-Bioactive Bone Substitutes Plc Files for Bankruptcy

MARKN.

BBS-Bioactive Bone Substitutes Plc | Company Release | February 12, 2025 at 17:00:00 EET

BBS-Bioactive Bone Substitutes Plc - Insider information: BBS-Bioactive Bone Substitutes Plc Files for Bankruptcy

The Board of Directors of BBS-Bioactive Bone Substitutes Plc has resolved that the Company will be filing for bankruptcy in the Oulu District Court. The company’s loan negotiations have ended without a positive result, which will prevent the Company from securing the necessary short-term liquidity to continue its’ operations.

“Despite extensive efforts to find a viable financial and operational solution, the Board of Directors has determined that the company cannot continue as a going concern”, comments the chairman of the board of directors Pekka Jalovaara.

The Oulu District Court will appoint a bankruptcy trustee to oversee the proceedings.

BBS-Bioactive Bone Substitutes Plc
Board of Directors
.

For more information, please contact:
Pekka Jalovaara, the Chairman of the Board
+358 50 5529 275
pekka.jalovaara@bbs-artebone.fi

Distribution
Nasdaq Helsinki
https://www.bbs-artebone.fi/

Certified Advisor:
Nordic Certified Adviser AB,
+46 70 551 67 29,
info@certifiedadviser.se

BBS in brief
BBS -Bioactive Bone Substitutes Plc is an orthobiology company that started its operations in 2003. We have developed a new product for the treatment of complex bone fractures and bone healing issues. Our goal is to provide next-generation medical products for the treatment of bone injuries in orthopedic surgery. In the pharmaceutical industry, the development and research work require perseverance and courage to innovate. We have a track record of over 20 years in this field. Our company is characterized by expertise, innovation, and dedicated employees who are passionate about their work. Our first developed product, ARTEBONE® Paste, is in the final stages of the CE marking process to enable its commercialization in the EU market. We are based in Oulu with a medical manufacturing facility in Reisjärvi, holding a manufacturing license. The company's headquarters are in Oulu, and we employ over 20 people.

BBS has been listed on Nasdaq First North Growth Market Finland since February 2018.

More information: www.bbs-artebone.fi

Attachments
BBS-Bioactive Bone Substitutes Plc - Insider information: BBS-Bioactive Bone Substitutes Plc Files for Bankruptcy

Datum 2025-02-12, kl 16:00
Källa MFN
Bifogade filer
BBS-Bioactive Bone Substitutes Plc - Insider information: BBS-Bioactive Bone Substitutes Plc Files for Bankruptcy
Hej Serverägare! Har du problem med troll och spam? Nu finns möjligheten att sätta en liten avgift, t.ex. 20kr, på discord invites och därmed stoppa många återkommande troll samtidigt som du tjänar lite pengar. Kolla in Invite Paywall.